Related trials
ZEST AMI (vs SES), 2009 - zotarolimus ES vs sirolimus ES
TRIANA, 2009 - primary ballon angioplasty vs tenecteplase
DEBATER (SES vs BMS), 2009 - sirolimus ES vs bare-metal stent
NORDISTEMI, 2009 - thrombolysis + angioplasty vs immediate thrombolysis
Juwana, 2009 - sirolimus ES vs paclitaxel ES
ZEST AMI (vs PES), 2009 - zotarolimus ES vs paclitaxel ES
PASEO, 2009 - drug ES vs bare-metal stent
CARESS, 2008 - thrombolysis + angioplasty vs immediate thrombolysis
HORIZONS-AMI Stent, 2008 - paclitaxel ES vs bare-metal stent
MISSION, 2008 - sirolimus ES vs bare-metal stent
DEDICATION, 2008 - drug ES vs bare-metal stent
Díaz de la Llera, 2007 - sirolimus ES vs bare-metal stent
SESAMI, 2007 - sirolimus ES vs bare-metal stent
TYPHOON, 2006 - sirolimus ES vs bare-metal stent
PROSIT, 2006 - sirolimus ES vs paclitaxel ES
HAAMU-STENT, 2006 - paclitaxel ES vs bare-metal stent
PASSION, 2006 - paclitaxel ES vs bare-metal stent
WEST, 2006 - systematic PCI (+stent) vs no systematic PCI
CAPITAL AMI, 2005 - thrombolysis + angioplasty vs immediate thrombolysis
Di Lorenzo et al., 2005 - sirolimus ES vs paclitaxel ES
ZWOLLE 6, 2005 - primary stenting vs ballon angioplasty
CAPITAL AMI, 2005 - systematic PCI (+stent) vs no systematic PCI
senior PAMI, 2005 - primary PCI vs thrombolytic therapy
STOPAMI 3, 2004 - primary stenting vs ballon angioplasty
GRACIA-1, 2004 - systematic PCI (+stent) vs no systematic PCI
See also:
All acute myocardial infarction clinical trials
All clinical trials of PCI
All clinical trials of systematic ballon angioplasty
|
|
TIMI II-A (defered) study, 0
|
|
|
Treatments
| Studied treatment |
delayed invasive strategy, deferred angiography and PTCA for 18-48 hours
|
| Control treatment |
conservative approach
|
Patients
Method and design
| Randomized effectives |
194 / 197 (studied vs. control) |
Results
No results available for this trial
- no clinical endpoint reported
Reference(s)
-
Rogers WJ, Baim DS, Gore JM, Brown BG, Roberts R, Williams DO, Chesebro JH, Babb JD, Sheehan FH, Wackers FJ.
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial..
Circulation 1990;81:1457-76
Pubmed
|
Hubmed
| Fulltext
|